BIOINFORMATICS SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Bioinformatics Services Market Size and Forecast – 2025 to 2032

The Global Bioinformatics Services Market is estimated to be valued at USD 3.72 Bn in 2025 and is expected to reach USD 9.60 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 14.5% from 2025 to 2032. This significant growth reflects increasing demand driven by advancements in genomics, proteomics, and personalized medicine, supported by rising investments in biotechnology and pharmaceutical sectors worldwide.

Key Takeaways of the Global Bioinformatics Services Market

• Sequence analysis services will hold the largest share of the global bioinformatics services market in 2025 at 28.4%.
• The genomics segment will lead the market by application with a 24.5% share in 2025.
• The pre-processing workflow segment will dominate the workflow classification, accounting for 34.6% of the market in 2025.
• North America is expected to lead the market, holding a share of 39.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with an estimated market share of 24.5% in 2025.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

How are Sequence Analysis Services Emerging as the Leading Growth Driver of the Bioinformatics Services Market?

In terms of service type, sequence analysis services are expected to contribute the highest share of 28.4% in 2025, owing to its pivotal role in decoding genetic information quickly and accurately. This segment has recorded a significant growth due to the constantly rising need of genomic sequencing in various areas of application like clinical research, agriculture and biotechnology.

Several companies demonstrate the accelerating momentum behind DNA sequence analysis services. Illumina’s BaseSpace platform scales high-throughput analysis for clinical labs and population genomics programs. Qiagen’s CLC Genomics Workbench provides integrated pipelines for variant calling, transcriptomics, and metagenomics. BGI Genomics delivers large-volume sequencing and downstream analysis services for global clients, supporting applications from oncology to pathogen surveillance.

https://www.dnanexus.com/genomic-data-analysis-software-platform

Why is the Genomics Segment Spearheading the Expansion of the Bioinformatics Services Market?

The genomics holds the largest share of the world bioinformatics services market at an estimated 24.5% in 2025, largely due to its whole scenario in the comprehension of the entire set of DNA in an organism.

The rising popularity of genomics services can be explained by the fact that their services are necessarily applied in the scope of research of diseases, development of medications, and personal healthcare. Genomic information can be used to investigate the molecular pathogenesis of genetic diseases and malignancies and can be utilized to discover new therapeutic targets and diagnostic bio-markers.

The high pace of genomics-driven bioinformatics services is demonstrated by a number of companies. The genomics England program is a massive national-wide program, which makes use of bioinformatics to a large number to process whole-genome data used in the processing of rare diseases and oncology.

https://www.genomicsengland.co.uk/

Why does the Pre-Processing Workflow Dominate the Bioinformatics Services Market?

The pre-processing workflow segment has the largest share in workflow classification with a projected share of 34.6% in 2025 because the workflow is the foundation of preparing raw biological data to its correct and dependable downstream analysis.

The main steps that it takes in pre-processing include quality control, data filtering, removal of contaminants and normalization which together guarantees the integrity and usefulness of the large and complex datasets produced by the high-throughput technologies.

Bioinformatics Service Pricing Benchmark & Regional Cost-per-Analysis Comparison

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Regional Insights

To learn more about this report, Download Free Sample

North America Bioinformatics Services Market Analysis and Trends

North America’s dominance in the global market for bioinformatics services, with a projected share of 39.3% in 2025, is enabled by the well-established healthcare infrastructure, heavy investment in research and development, and the existence of many biotech and pharmaceutical companies. The national support provided by the government to the U.S. and Canada is good as it encourages innovation in bioinformatics services, such as the National Institutes of Health (NIH) and other projects on the genome.

Familiar organizations like Thermo Fisher scientific, illumina, and IBM Watson health have played a key role in providing the latest bioinformatics software and solutions that aid in drug discovery, genomic research and personalized medicine.

https://www.thermofisher.com/in/en/home/life-science/sequencing/next-generation-sequencing/ion-torrent-next-generation-sequencing-products-services/ngs-bioinformatics-services.html

Asia Pacific Bioinformatics Services Market Analysis and Trends

The bioinformatics services market has a high growth potential in Asia Pacific region, with a projected share of 24.5% in 2025. This is attributed to the growing healthcare infrastructure, government investments in biotechnology, and number of skilled bioinformatics professionals. China, India, Japan and South Korea are reinforcing digital health and genomics with national programs on a large scale, enhancing the quality of data systems and regulations.

The market growth is being driven by the fast-paced adoption of NGS and bioinformatics tools in research and clinical environments. BGI Group (China), Strand Life Sciences (India) and Macogen (South Korea) are considered to be the leaders in the market and they play the major role in providing the affordable sequencing and data analysis services and therefore bioinformatics is now more accessible in the region.

https://en.genomics.cn/en-gsequencing.html

Global Bioinformatics Services Market Outlook for Key Countries

U.S. Bioinformatics Services Market Trends

The U.S. market for bioinformatics services is flourishing because it has a good technological base and well-developed funding systems. The major pharmaceutical and biotechnology firms, such as Thermo Fisher Scientific and Illumina, spend excessively on the creation of novel bioinformatics-based solutions that can support both personalized medicine and bigger genomic initiatives. The development of AI-powered data analytics in healthcare applications is supported by public-private projects and government-funded research, and this trend keeps the U.S. as a world leader in bioinformatics services.

China Bioinformatics Services Market Trends

The bioinformatics market in China is fast developing, which is backed by government initiatives such as Made in China 2025, and tremendous investments in genomics and precision medicine. As an organization of one of the largest genomics in the world, BGI Group leads the way in the field of sequencing and data analytics, and China is a very strong competitor in bioinformatics services. Large population and increasing healthcare need of the country gives the country a special opportunity to apply bioinformatics in large scale, specifically population genomics and disease research.

India Bioinformatics Services Market Trends

The market in India also has an advantage of good pool of talent in the field of bioinformatics and competitive outsourcing. Strand Life Sciences and MedGenome are other companies that are cutting out a solid niche by offering genomics analysis services and clinical bio-informatics services both locally and globally. India has become the heart of cost-effective service delivery as well as innovation due to government efforts to improve biotechnology infrastructure and fund research.

Germany Bioinformatics Services Market Trends

Germany is one of the most developed European markets with developed healthcare systems and a high presence of the biotech industry. It is a well-established and valuable academic-industrial cooperation in the country, which is facilitated by such programs as German Bioinformatics Resource Network. The European presence of firms like Qiagen and Illumina provides advanced bioinformatics applications that facilitate translational research and pharmaceutical discovery which solidifies the position of Germany in the European bioinformatics scene.

Japan Bioinformatics Services Market Trends

The bioinformatics services market in Japan is characterized by a wide support of personalized medicine and biomedical research on the part of the government. The use of bioinformatics tools in clinical and academic research is closely connected with the programs targeted at next-generation sequencing and big data analytics. Japanese firms such as Macrogen and RIKEN are the leaders in innovation especially in the area of data integration and computational biology making Japan a major player in the development of bioinformatics in Asia Pacific.

Global & Regional Capability Footprint of Leading Bioinformatics Service Providers

• Global bioinformatics providers concentrate high sequencing throughput and advanced compute capacity in the U.S., Western Europe, Japan, and Singapore. They operate large multi-platform NGS facilities supported by GPU-enabled HPC clusters and deep cloud integration, enabling rapid processing of large genomic and multi-omics datasets for clinical and pharmaceutical clients.
• Regional players in India, China, Eastern Europe, and LATAM focus on high-volume, cost-efficient sequencing supported by hybrid HPC–cloud setups. Their capabilities emphasize routine genomics, population studies, and backend analysis for global partners, forming the industry’s throughput engine while premium interpretive work remains concentrated in top-tier markets.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In August 2025, Zifo, a global informatics and AI solutions provider, launched its new AI Antibody Engineering app on the Snowflake Marketplace to accelerate Bioinformatics Services and drug discovery. The Snowflake team supported this launch through its secure cloud infrastructure that enables scalable AI workloads. The platform lets scientists design and optimize therapeutic antibodies faster through protein language models trained within Snowflake.
• In April 2025, Signios Bio, a U.S.-based biotechnology company specializing in multiomics and Bioinformatics Services, launched its new brand as it separated from MedGenome’s former research division. Signios Bio provides AI-driven genomics, proteomics, metabolomics, spatial biology, and advanced multiomic analysis for precision medicine and drug discovery. The company aims to help researchers decode complex disease biology and accelerate targeted therapy development through its proprietary bioinformatics platform.
• In September 2024, Almaden Genomics, a bioinformatics and data management solutions company, launched a new Data Management and Informatics Services business to strengthen its Bioinformatics Services portfolio. Almaden Genomics aims to support drug discovery, diagnostics, and biotech research through scalable cloud solutions, custom bioinformatics pipelines, and advanced multimodal data management. The company focuses on simplifying complex data ingestion, governance, and analysis to help researchers accelerate scientific discovery.
• In July 2023, FOXO Technologies, a developer of epigenetic analysis tools, launched new Bioinformatics Services to enhance the processing and interpretation of epigenetic data and accelerate breakthroughs in biology and healthcare.

Top Strategies Followed by Global Bioinformatics Services Market Players

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Report Scope

Bioinformatics Services Market Report Coverage

Bioinformatics Services Market Dynamics

To learn more about this report, Download Free Sample

Bioinformatics Services Market Driver - Rapid Growth in Next Generation Sequencing Based Research

The rapid currency of next-generation sequencing (NGS) technologies has turned into one of the essential catalysts of the growth of the market of bioinformatics services on the global arena. With the continued development of sequencing platforms that provide increased throughput with lower prices, academicians, pharmaceutical, and clinical diagnostic researchers are producing massive volumes of complex genomic data. This proliferation of data also requires more sophisticated bioinformatics storage, analysis, and interpretation, thereby spurring the need to use highly sophisticated computational tools and professional services. In addition, NGS uses are not limited to genomics to transcriptomics, epigenomics, and metagenomics to widen the scope of bioinformatics services needed to address the various forms of data.

Rapid NGS adoption is clear from the growth of companies like Element Biosciences, which offers high-throughput sequencing systems that generate massive datasets requiring specialized bioinformatics support. PacBio also drives this demand through long-read sequencing advancements that produce complex genomic, epigenomic, and transcriptomic data, increasing reliance on external bioinformatics services for accurate interpretation.

Bioinformatics Services Market Opportunity - Growing Adoption of Cloud-Based and AI-Enabled Bioinformatics Platforms

The world market of bioinformatics services faces a massive opportunity due to the growing use of cloud-based and AI-enabled bioinformatics services. These cutting-edge technologies are transforming the manner in which biological data is analyzed, stored, and interpreted and provide faster and more accurate insights, which are of utmost value in genomics, drug discovery, and personalized medicine. Cloud-based systems provide scalable and affordable solutions to researchers and organizations to handle large amounts of complicated biological data without the on-premise infrastructure constraints. Such flexibility also enables cooperation between geographically dispersed teams, which speeds up the research and development processes.

Cloud and AI-enabled platforms are expanding due to players like DNAnexus, which provides cloud-native bioinformatics environments used by global pharma teams for large-scale genomic analysis. Seven Bridges accelerates multiomic research through AI-powered workflows deployed on secure cloud infrastructure, enabling distributed R&D teams to analyze high-complexity datasets without on-premise limitations.

Analyst Opinion (Expert Opinion)

• The market of bioinformatics services is growing, with NGS, cloud analytics, and AI simplifying the interpretation of genomic data and becoming more correct, and government-funded genomics programs becoming more powerful in long-term demand. The issue of privacy, lack of infrastructure and availability of trained bioinformaticians are all still a reality, yet the future is evident: increased automation, even further clinical integration, and increased international cooperations. Large-scale events like Bio-IT World, ASHG and the Global Digital Health Forum have played a catalyst role in this change by setting standards, demonstrating sophisticated analytical tools and bringing policy discussions on data use and interoperability.
• New directions in the industry such as Illumina, QIAGEN and Thermo Fisher upgrading their cloud informatics operations indicate that the market is shifting towards scalable, end-to-end solutions. In the U.S., national programs like All of Us, as well as Genome India and the Genomic Medicine Service in the U.K., are all contributing to the consistent demand of services, and relationships between service providers and clinics such as Mayo Clinic’s AI-based genomic interpretation programs are also demonstrating the role of service providers in clinical decision-making.

Market Segmentation

• Service Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Sequence Analysis Services
  • Proteomics Analysis Services
  • Gene Expression and Functional Analysis Services
  • Biomarker Discovery Services
  • Clinical Bioinformatics Services
  • Cheminformatics and Drug Discovery Services
  • Data Management and Storage Services
  • Statistical and Computational Modelling Services
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics and Lipidomics
  • Drug Discovery and Development
  • Precision Medicine
  • Agricultural Research
  • Environmental Research
• Workflow Insights (Revenue, USD Bn, 2020 - 2032)
  • Pre-Processing Workflow
  • Primary Analysis Workflow
  • Secondary Analysis Workflow
  • Tertiary Analysis Workflow
• Deployment Model Insights (Revenue, USD Bn, 2020 - 2032)
  • On-Premise
  • Cloud-Based
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Clinical Diagnostic Laboratories
  • Agricultural and Environmental Testing Laboratories
  • Contract Research Organizations (CROs)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Illumina
  • QIAGEN
  • BGI Genomics
  • Thermo Fisher Scientific
  • F Hoffmann La Roche
  • PerkinElmer
  • Agilent Technologies
  • Eurofins Scientific
  • Bio Rad Laboratories
  • GENEWIZ
  • DNAnexus
  • Fios Genomics
  • Seven Bridges Genomics
  • Charles River Laboratories
  • Labcorp

Sources

Primary Research Interviews

• Industry Stakeholders
  • Academic research laboratories
  • Bioinformatics service providers
• End Users
  • Pharmaceutical and biotechnology companies
  • Clinical diagnostics labs

Government and International Databases

• National Institutes of Health (NIH)
• National Center for Biotechnology Information (NCBI)
• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• OECD Health Data

Trade Publications

• GenomeWeb
• Bio-IT World
• FierceBiotech
• Genetic Engineering & Biotechnology News (GEN)
• Clinical OMICS
• Technology Networks – Bioinformatics

Academic Journals

• Bioinformatics (Oxford)
• Journal of Biomedical Informatics
• BMC Bioinformatics
• Nucleic Acids Research
• PLOS Computational Biology
• Briefings in Bioinformatics

Reputable Newspapers

• The New York Times – Science
• The Guardian – Science
• The Washington Post – Health
• Financial Times – Healthcare & Pharma
• The Wall Street Journal – Health
• BBC News – Science & Health

Industry Associations

• International Society for Computational Biology (ISCB)
• American Medical Informatics Association (AMIA)
• European Federation for Medical Informatics (EFMI)
• Human Genome Organisation (HUGO)
• Global Alliance for Genomics and Health (GA4GH)
• IEEE Computational Intelligence Society

Public Domain Resources

• GenBank
• EMBL-EBI Resources
• Human Protein Atlas
• Open Science Framework (OSF)
• GitHub Open Bioinformatics Repositories

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years